+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Carcinoma Drug"

From
From
Nasopharyngeal Carcinoma Treatment Market Report 2025 - Product Thumbnail Image

Nasopharyngeal Carcinoma Treatment Market Report 2025

  • Report
  • March 2025
  • 200 Pages
  • Global
From
Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 240 Pages
  • Global
From
Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Hepatocellular Carcinoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 200 Pages
  • Global
From
Cutaneous Squamous Cell Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Cutaneous Squamous Cell Carcinoma- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 120 Pages
  • Global
From
Hepatocellular Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Hepatocellular Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 230 Pages
  • Global
From
Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Advanced Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 50 Pages
  • Global
From
Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Merkel Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 90 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 150 Pages
  • Global
From
From
Transitional Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Transitional Cell Carcinoma - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025 - Product Thumbnail Image

Esophageal Squamous Cell Carcinoma - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Head And Neck Squamous Cell Carcinoma (HNSCC) - Pipeline Insight, 2025 - Product Thumbnail Image

Head And Neck Squamous Cell Carcinoma (HNSCC) - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
From
From
From
From
Metastatic Hepatocellular Carcinoma- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Hepatocellular Carcinoma- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Loading Indicator

Carcinoma drugs are a type of oncology drug used to treat cancer. They are designed to target and destroy cancer cells while minimizing damage to healthy cells. Carcinoma drugs can be administered orally, intravenously, or topically, depending on the type of cancer being treated. Common types of carcinoma drugs include chemotherapy, targeted therapy, immunotherapy, and hormone therapy. Chemotherapy is a type of carcinoma drug that uses drugs to kill cancer cells. Targeted therapy is a type of drug that targets specific molecules in cancer cells, such as proteins or genes, to stop the growth and spread of cancer. Immunotherapy is a type of drug that helps the body’s immune system fight cancer. Hormone therapy is a type of drug that blocks hormones that can cause cancer cells to grow. The carcinoma drug market is highly competitive, with many companies offering a variety of treatments. Some of the major players in the market include Bristol-Myers Squibb, Merck & Co., Pfizer, Novartis, and Roche. Other companies in the market include AstraZeneca, Eli Lilly, GlaxoSmithKline, and Sanofi. Show Less Read more